Cell division cycle‐associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma

Abstract Background Cell division cycle‐associated 8 (CDCA8) is involved in numerous signaling networks, and it serves a crucial modulatory function in multiple malignant tumors. However, its significance in prognosis and immune infiltration in hepatocellular carcinoma (HCC) remains unclear. Materia...

Full description

Bibliographic Details
Main Authors: Haomin Wu, Shiqi Liu, Di Wu, Haonan Zhou, Guoxin Sui, Gang Wu
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.5718
_version_ 1827951711975636992
author Haomin Wu
Shiqi Liu
Di Wu
Haonan Zhou
Guoxin Sui
Gang Wu
author_facet Haomin Wu
Shiqi Liu
Di Wu
Haonan Zhou
Guoxin Sui
Gang Wu
author_sort Haomin Wu
collection DOAJ
description Abstract Background Cell division cycle‐associated 8 (CDCA8) is involved in numerous signaling networks, and it serves a crucial modulatory function in multiple malignant tumors. However, its significance in prognosis and immune infiltration in hepatocellular carcinoma (HCC) remains unclear. Materials and methods Herein, we examined the CDCA8 levels in tumor tissues, as well as its associated signaling pathways and correlation with immune infiltration. Additionally, we further clarified the prognostic significance of CDCA8 among HCC patients. HCC patient information was recruited from The Cancer Genome Atlas (TCGA). Using bioinformatics, the following parameters were analyzed among HCC patients: CDCA8 expression, enrichment analysis, immune infiltration, and prognosis analysis. Moreover, we employed in vitro investigations, such as, qRT‐PCR, immunohistochemistry (IHC), and cell functional experiments to validate our results. Results Elevated CDCA8 expression in HCC patients was markedly associated with T stage, pathological status (PS), tumor status (TS), histologic grade (HG), and AFP. Elevated CDCA8 expression HCC patients exhibited reduced overall survival (OS) (p < 0.001), disease‐specific survival (DSS) (p < 0.001), and progress free interval (PFI) H(p < 0.001). According to the ROC analysis, the area under the curve (AUC) was 0.997. Multivariate analysis revealed that CDCA8 was a stand‐alone prognostic indicator of patient OS (p = 0.009) and DSS (p = 0.006). A nomogram was then generated based on the multivariate analysis, and the C‐indexes and calibration chart revealed excellent predictive performance in determining HCC patient outcome. Based on the GSEA analysis, CDCA8 modulated the P53, Notch, PPAR, E2F networks. We observed a direct link between CDCA8 levels and Th2 and T helper cells, and a negative link between CDCA8 levels and dendritic cells (DC), neutrophils, cytotoxic cells, and CD8 T cells. Furthermore, CDCA8 deficiency inhibited liver cancer cell proliferation and invasion. Conclusion In conclusion, these findings indicate that CDCA8 is a new molecular bioindicator of HCC patient prognosis, and it is an excellent candidate for therapeutic target against HCC.
first_indexed 2024-04-09T13:46:26Z
format Article
id doaj.art-e9396dc6094043c483839138f26e0883
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-04-09T13:46:26Z
publishDate 2023-04-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-e9396dc6094043c483839138f26e08832023-05-09T04:04:19ZengWileyCancer Medicine2045-76342023-04-01128101381015510.1002/cam4.5718Cell division cycle‐associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinomaHaomin Wu0Shiqi Liu1Di Wu2Haonan Zhou3Guoxin Sui4Gang Wu5Department of General Surgery The First Hospital of China Medical University Shenyang ChinaDepartment of General Surgery The First Hospital of China Medical University Shenyang ChinaDepartment of General Surgery The First Hospital of China Medical University Shenyang ChinaDepartment of General Surgery The First Hospital of China Medical University Shenyang ChinaDepartment of General Surgery The First Hospital of China Medical University Shenyang ChinaDepartment of General Surgery The First Hospital of China Medical University Shenyang ChinaAbstract Background Cell division cycle‐associated 8 (CDCA8) is involved in numerous signaling networks, and it serves a crucial modulatory function in multiple malignant tumors. However, its significance in prognosis and immune infiltration in hepatocellular carcinoma (HCC) remains unclear. Materials and methods Herein, we examined the CDCA8 levels in tumor tissues, as well as its associated signaling pathways and correlation with immune infiltration. Additionally, we further clarified the prognostic significance of CDCA8 among HCC patients. HCC patient information was recruited from The Cancer Genome Atlas (TCGA). Using bioinformatics, the following parameters were analyzed among HCC patients: CDCA8 expression, enrichment analysis, immune infiltration, and prognosis analysis. Moreover, we employed in vitro investigations, such as, qRT‐PCR, immunohistochemistry (IHC), and cell functional experiments to validate our results. Results Elevated CDCA8 expression in HCC patients was markedly associated with T stage, pathological status (PS), tumor status (TS), histologic grade (HG), and AFP. Elevated CDCA8 expression HCC patients exhibited reduced overall survival (OS) (p < 0.001), disease‐specific survival (DSS) (p < 0.001), and progress free interval (PFI) H(p < 0.001). According to the ROC analysis, the area under the curve (AUC) was 0.997. Multivariate analysis revealed that CDCA8 was a stand‐alone prognostic indicator of patient OS (p = 0.009) and DSS (p = 0.006). A nomogram was then generated based on the multivariate analysis, and the C‐indexes and calibration chart revealed excellent predictive performance in determining HCC patient outcome. Based on the GSEA analysis, CDCA8 modulated the P53, Notch, PPAR, E2F networks. We observed a direct link between CDCA8 levels and Th2 and T helper cells, and a negative link between CDCA8 levels and dendritic cells (DC), neutrophils, cytotoxic cells, and CD8 T cells. Furthermore, CDCA8 deficiency inhibited liver cancer cell proliferation and invasion. Conclusion In conclusion, these findings indicate that CDCA8 is a new molecular bioindicator of HCC patient prognosis, and it is an excellent candidate for therapeutic target against HCC.https://doi.org/10.1002/cam4.5718biomarkerCDCA8HCCimmune infiltrationprognosis
spellingShingle Haomin Wu
Shiqi Liu
Di Wu
Haonan Zhou
Guoxin Sui
Gang Wu
Cell division cycle‐associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma
Cancer Medicine
biomarker
CDCA8
HCC
immune infiltration
prognosis
title Cell division cycle‐associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma
title_full Cell division cycle‐associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma
title_fullStr Cell division cycle‐associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma
title_full_unstemmed Cell division cycle‐associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma
title_short Cell division cycle‐associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma
title_sort cell division cycle associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma
topic biomarker
CDCA8
HCC
immune infiltration
prognosis
url https://doi.org/10.1002/cam4.5718
work_keys_str_mv AT haominwu celldivisioncycleassociated8isaprognosticbiomarkerrelatedtoimmuneinvasioninhepatocellularcarcinoma
AT shiqiliu celldivisioncycleassociated8isaprognosticbiomarkerrelatedtoimmuneinvasioninhepatocellularcarcinoma
AT diwu celldivisioncycleassociated8isaprognosticbiomarkerrelatedtoimmuneinvasioninhepatocellularcarcinoma
AT haonanzhou celldivisioncycleassociated8isaprognosticbiomarkerrelatedtoimmuneinvasioninhepatocellularcarcinoma
AT guoxinsui celldivisioncycleassociated8isaprognosticbiomarkerrelatedtoimmuneinvasioninhepatocellularcarcinoma
AT gangwu celldivisioncycleassociated8isaprognosticbiomarkerrelatedtoimmuneinvasioninhepatocellularcarcinoma